Erlotinib Completed Phase 1 Trials for Extrahepatic Bile Duct Cancer / Small Intestine Cancer / Cancer of the Gallbladder / Malignant Neoplasm of Pancreas / Periampullary Adenocarcinoma / Liver Cancer Treatment

Indications	Status	Purpose	Phase
DBCOND0028665 (Extrahepatic Bile Duct Cancer) DBCOND0028490 (Small Intestine Cancer) DBCOND0034881 (Cancer of the Gallbladder) DBCOND0087260 (Malignant Neoplasm of Pancreas) DBCOND0042952 (Periampullary Adenocarcinoma) DBCOND0028488 (Liver Cancer)	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT00987766	Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer	Erlotinib (DB00530) Gemcitabine (DB00441) Oxaliplatin (DB00526)